InvestorsHub Logo
Followers 72
Posts 4228
Boards Moderated 2
Alias Born 08/21/2015

Re: Djdjdjdj post# 23243

Saturday, 06/16/2018 1:14:57 AM

Saturday, June 16, 2018 1:14:57 AM

Post# of 28118
These were filed a little while ago... In case you are wondering. Who knows if they will come to life though

https://www.prnewswire.com/news-releases/new-provisional-patents-filed-for-pharmaceutical-cannabidiol-cbd-formulation-consisting-of-ibuprofen--cbd-compounds-aimed-at-treating-pain-289143571.html

Here is another article...

https://www.benzinga.com/trading-ideas/long-ideas/15/02/5244533/5-marijuana-stocks-getting-investors-high-and-7-key-post-lega

The company, which recently switched focus from sugar alternatives to cannabis, has released a series of press relating to the filing of provisional patents for its CBD based pain medication, which is actually a mix of cannabidiol and ibuprofen.

In a January 29 release, George Blankenbaker, President of Stevia Corp stated:

“We believe that there will be significant advantages of using these four very effective drugs in combination with cannabidiol as opposed to using these drugs alone. Acetaminophen, Ibuprofen, Naproxen and Aspirin generate billions of dollars in sales each year. Our four provisional patent applications include 63 claims in total and we look forward to filing the utility patents over the next 12 months. We strongly believe that our intellectual property strategy, if successfully implemented, will provide us a competitive advantage over other healthcare companies using cannabinoids for human healthcare.”